Somnigroup heads into its third-quarter report with a split personality. The margin and synergy machine built around Tempur Sealy and Mattress Firm is humming, yet the demand backdrop that feeds it has clearly cooled. Management cut full-year guidance last quarter for the first time in recent memory, and the November 9 release, due before the opening bell, will show which of those two forces is winning.

The Street is asking for a lot. Consensus calls for earnings of $1.06 a share, up 11.6% from $0.95 a year ago, on revenue of $2.43 billion, a 14.5% jump from $2.12 billion. That top-line growth stands out against management's own view that the bedding industry will shrink by a mid-single-digit percentage this year and that Mattress Firm like-for-like sales will slip slightly. Growth of that size in a contracting market almost certainly leans on portfolio changes, including the Leggett & Platt combination that management said should close before the end of the third quarter. Investors should look closely at how much of any revenue figure is organic, because acquired sales can flatter the headline while the core business treads water.

Guidance is the more telling tension. Somnigroup lowered its 2026 adjusted EPS outlook to $2.85 to $3.15 from $3.00 to $3.40, trimmed its sales midpoint to about $7.6 billion and its EBITDA midpoint to roughly $1.39 billion. Full-year consensus of $3.15 sits right at the top of the new range, meaning analysts have essentially assumed the cut was conservative. That leaves little cushion. A quarter that lands near consensus but comes with a range narrowed toward the midpoint could still read as a disappointment, while a reaffirmed range with signs of stabilizing demand would validate the Street's optimism.

The operational scorecard is fairly clear. On the positive side, Tempur Sealy North America posted a 61.8% adjusted gross margin and a 26.7% operating margin last quarter, lifted by synergies and productivity, and its share of Mattress Firm's floor rose to the mid-60s percent, pushing the expected incremental EBITDA benefit to $65 million from $40 million. Holding those margins while volumes soften would confirm the integration thesis is durable rather than a one-time step-up. Progress on Kingsdown's expansion from 200 to roughly 800 Mattress Firm stores, continued strength abroad, and free cash flow that keeps leverage near the 3x target would all reinforce that story. On the negative side, the weak July 4th period left Mattress Firm same-store sales flat afterward, a sharp turn from the robust trend described earlier in the year. Any sign that softness deepened through the late summer, that entry-level demand eroded further in a K-shaped market, or that Dreams UK's ERP troubles lingered would challenge management's framing of these issues as transitory. Middle East commodity pressure and higher consumer financing costs are also swing factors for margins.

Expectations have warmed modestly even as the stock has not. Sentiment readings improved to mildly bullish from nearly neutral heading into the last report, but shares have slipped 2.7% since then, slightly lagging the S&P 500. At $63.56, the stock trades well below its 200-day moving average of $73.76 and sits in the lower part of its post-earnings range of roughly $60 to $71, a sign the market remains skeptical despite the improved mood.

Ultimately, this report hinges on whether self-help can offset a shrinking market. Management has already signaled that its 2028 target of $5.15 will likely come down. If synergies, Leggett and margin discipline keep the full-year range intact with consensus still credible near the top, the guidance cut will look like a reset rather than the start of a slide. If demand weakness forces another trim, the integration story will be fighting a much steeper hill.